SI1252192T1 - Enhancing the circulating half-life of antibody-based fusion proteins - Google Patents

Enhancing the circulating half-life of antibody-based fusion proteins

Info

Publication number
SI1252192T1
SI1252192T1 SI200130649T SI200130649T SI1252192T1 SI 1252192 T1 SI1252192 T1 SI 1252192T1 SI 200130649 T SI200130649 T SI 200130649T SI 200130649 T SI200130649 T SI 200130649T SI 1252192 T1 SI1252192 T1 SI 1252192T1
Authority
SI
Slovenia
Prior art keywords
antibody
enhancing
life
fusion proteins
circulating half
Prior art date
Application number
SI200130649T
Other languages
Slovenian (sl)
Inventor
Stephen D Gillies
Christa Burger
Kin Ming Lo
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Priority claimed from EP01916083A external-priority patent/EP1252192B1/en
Publication of SI1252192T1 publication Critical patent/SI1252192T1/en

Links

SI200130649T 2000-02-11 2001-02-09 Enhancing the circulating half-life of antibody-based fusion proteins SI1252192T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18176800P 2000-02-11 2000-02-11
EP01916083A EP1252192B1 (en) 2000-02-11 2001-02-09 Enhancing the circulating half-life of antibody-based fusion proteins
PCT/US2001/004455 WO2001058957A2 (en) 2000-02-11 2001-02-09 Enhancing the circulating half-life of antibody-based fusion proteins

Publications (1)

Publication Number Publication Date
SI1252192T1 true SI1252192T1 (en) 2007-02-28

Family

ID=37774999

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130649T SI1252192T1 (en) 2000-02-11 2001-02-09 Enhancing the circulating half-life of antibody-based fusion proteins

Country Status (1)

Country Link
SI (1) SI1252192T1 (en)

Similar Documents

Publication Publication Date Title
HK1036286A1 (en) Enhancing the circulating half-life of antibody-based fusion proteins
HUP0302529A3 (en) Glp-1 fusion proteins
EP1423136A4 (en) Polypeptide conjugates with extended circulating half-lives
EP1463752A4 (en) Albumin fusion proteins
IL202255A0 (en) Binding domain-immunoglobulin fusion proteins
IL166751A0 (en) Modified transferin-antibody fusion proteins
GB9718609D0 (en) Fusion protein
NL1011875A1 (en) New connection.
EP1088888A4 (en) Fused protein
AU2001291049A1 (en) Defensin-antigen fusion proteins
ZA9810271B (en) Fused pyrazine compounds
GB9913437D0 (en) Fusion proteins
BR9901328B1 (en) fuser member.
NO20021275D0 (en) Transgent produced fusion proteins
SI1252192T1 (en) Enhancing the circulating half-life of antibody-based fusion proteins
DK0862197T3 (en) Fused Connection
NO20021244D0 (en) Subunit-optimized fusion proteins
MXPA03004939A (en) Synthesis of fused pyrrolecarboxamides.
GB9811516D0 (en) Fusion proteins having increased half-lives
EP1127066A4 (en) Modified proteins
ZA200204485B (en) Fused tri-heterocyclic compounds.
GB9803757D0 (en) Fusion proteins
GB9813653D0 (en) Fusion proteins
GB9813018D0 (en) CD8-›2m fusion proteins
SE0002432D0 (en) Fusion vectors II